Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

ProQR Therapeutics N.V (PRQR) Assets Average: 2021-2025

Historic Assets Average for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to $150,529.

  • ProQR Therapeutics N.V's Assets Average rose 23.15% to $150,529 in Q3 2025 from the same period last year, while for Sep 2025 it was $150,529, marking a year-over-year increase of 23.15%. This contributed to the annual value of $164.3 million for FY2024, which is 1.45% up from last year.
  • As of Q3 2025, ProQR Therapeutics N.V's Assets Average stood at $150,529, which was down 4.50% from $157,623 recorded in Q2 2025.
  • ProQR Therapeutics N.V's Assets Average's 5-year high stood at $235.1 million during Q4 2021, with a 5-year trough of $122,237 in Q3 2024.
  • For the 3-year period, ProQR Therapeutics N.V's Assets Average averaged around $65.6 million, with its median value being $169,519 (2025).
  • In the last 5 years, ProQR Therapeutics N.V's Assets Average spiked by 106.80% in 2022 and then slumped by 99.92% in 2024.
  • Quarterly analysis of 5 years shows ProQR Therapeutics N.V's Assets Average stood at $235.1 million in 2021, then plummeted by 36.71% to $148.8 million in 2022, then increased by 1.83% to $151.5 million in 2023, then plummeted by 99.90% to $148,412 in 2024, then climbed by 23.15% to $150,529 in 2025.
  • Its Assets Average was $150,529 in Q3 2025, compared to $157,623 in Q2 2025 and $169,519 in Q1 2025.